The global depression treatment market, valued at USD 11 billion in 2024, is poised for steady growth, projected to reach USD 18.3 billion by 2034 at a CAGR of 5.2%. This expansion is driven by ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other psychedelic ...

Relief Mental Health, a leading outpatient provider of mental health treatment, is proud to announce its recognition as the ...

H.C. Wainwright tells investors in a research note that Compass Pathways (CMPS) is one of the most compelling stories in neuropsychiatry, and ...

Ketamine has long been used in medical settings as an anesthetic and painkiller, particularly in emergency cases where other ...

Dennis Dlugos, MD, MSCE; Jacqueline French, MD; Terrence O'Brien, MD; Jo Sourbron, MD, PhD, MPharm; and Joseph Sullivan, MD, bring decades of ...

Ketamine is often viewed more as a party drug than a medicine. One Columbia clinic is using the drug to help patients with ...